“…Patients with positive surgical margins, perineural invasion, lymph node involvement, presence of ENE constitute a subgroup of patients with high risk of locoregional relapse. [14][15][16][17][18] Besides all of these prognostic factors, numerous reports have pointed out the prognostic value of anemia and the adverse effects of tumor hypoxia on the efficacy of anticancer treatments in recent years, indicating that decreased radiosensitivity resulting from tumor hypoxia was the most likely explanation. 1 a Low \120 g/l in women and \130 g/l in men b High C20 g/l in women and C130 g/l in men OS overall survival, DFS disease-free survival, CSS cancer-specific survival, LRC locoregional control, CI confidence interval, RT radiotherapy, ENE extracapsular nodal extension pre-radiotherapy Hb level, and interruptions during RT [1 week were important prognostic factors for outcome of radiochemotherapy treatment.…”